Acute Porphyria Drug Database

A06AD15 - Macrogol
Not porphyrinogenic
NP

Rationale
Macrogols are not absorbed from the gastrointestinal tract.
Chemical description
Mixtures of long, linear polymers.
Therapeutic characteristics
Macrogols are used as osmotic laxatives. A solution of macrogol 3350 (or 4000) is used for the treatment of chronic constipation in a usual oral dose of 125 mL up to three times daily. Common adverse reactions of macrogols that can be confused with an acute porphyric attack are gastrointestinal discomfort, bloating, and nausea.
Metabolism and pharmacokinetics
Not absorbed from the garstrointerstinal tract, eliminated in feces.
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.

References

  1. Drug reference publications
  2. Sweetman SC, editor. Martindale: The complete drug reference. Macrogols. Pharmaceutical Press 2009. #1091

Similar drugs
Explore alternative drugs in similar therapeutic classes A06A / A06AD or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙